A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 7, 2015

Primary Completion Date

December 4, 2017

Study Completion Date

January 17, 2018

Conditions
Rheumatoid ArthritisCongenital Hip DysplasiaAvascular Necrosis
Interventions
DEVICE

Total Hip System made in China (SUN, CoCr, Duraloc, Marathon)

SUN Hip stem,CoCr Femoral Head,Duraloc Porocoat Sector acetabular shell,Marathon 10D polyethylene liner (ETO)

DEVICE

Total Hip System made outside of China (Summit, CoCr, Duraloc, Marathon)

Summit Porocoat STD,CoCr Femoral Head,Duraloc Porocoat Sector acetabular shell,Marathon 10D polyethylene liner (ETO)

Trial Locations (8)

Unknown

The first affiliated hospital of Guangzhou Tranditional Meidical University, Guangzhou

The third affiliated hospital of Hebei University, Shijiazhuang

The second affiiliated hospital of Harbin Medical University, Harbin

The first affiliated hospital of Nanchang University, Nanchang

The affiliated hosoital of Ningxia Medical University, Yinchuan

The First Affiliated Hospital of Xinjiang Medicine University, Hohhot

The general hospital of Kunming, Kunming

The second Affiliated Hospital of Zhejiang Medicine University, Hangzhou

All Listed Sponsors
lead

Johnson & Johnson Medical (Suzhou) Ltd.

INDUSTRY

NCT02399007 - A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China | Biotech Hunter | Biotech Hunter